Ray Hill

Ray Hill

Director/Board Member at ADDEX THERAPEUTICS LTD

Net worth: 90 822 $ as of 2024-04-29

79 year
Health Technology
Commercial Services
Consumer Services

Profile

Raymond George Hill is currently the Chairman at.
Avilex Pharma ApS.
He also holds the position of Non-Executive Director at Addex Therapeutics Ltd.
since 2015.
Additionally, he is a Member of The Research Board, Inc. and the Royal Pharmaceutical Society.
In his former roles, Hill served as the Chairman at Merck & Co., Inc. from 2008 to 2008.
He was also the President & Chairman-Trustees Council at the British Pharmacological Society from 2011 to 2012.
Hill worked as an Independent Director at Orexo AB from 2008 to 2019.
He was a Non-Executive Director at Lectus Therapeutics Ltd.
and Addex Therapeutics Ltd.
from 2008 to 2013.
Hill held the position of Executive Director-Licensing & External Research at Merck Sharp & Dohme Research Laboratories from 2002 to 2008.
He was an Executive Director at Merck Sharp & Dohme Corp.
from 1990 to 2008.
Hill also served as the Group Director-Pharmacology at SKF (U.K.) Ltd.
and as the Executive Director-Pharmacology at Neuroscience Research Centre from 1990 to 2002.
He was an Independent Director at Asceneuron SA and a Member-Park Davis Research Unit at the University of Cambridge.
Hill was a Director-Supervisory Board at Covagen AG and a Director at Karolinska Development AB.
He was also a Council Member at the Academy of Medical Sciences in 2013.
Dr. Hill completed his undergraduate and doctorate degrees at the University of London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-28 1,365,532 ( 0.74% ) 90 822 $ 2024-04-29

Ray Hill active positions

CompaniesPositionStart
ADDEX THERAPEUTICS LTD Director/Board Member 2015-06-10
Corporate Officer/Principal -
Chairman -
Corporate Officer/Principal -
All active positions of Ray Hill

Former positions of Ray Hill

CompaniesPositionEnd
OREXO AB Director/Board Member 2018-12-31
ADDEX THERAPEUTICS LTD Director/Board Member 2013-03-19
Merck Sharp & Dohme Research Laboratories Corporate Officer/Principal 2008-04-29
Director/Board Member 2007-12-31
MERCK & CO., INC. Chairman 2007-12-31
See the detail of Ray Hill's experience

Training of Ray Hill

University of London Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ray Hill's experience

Connections

100 +

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
MERCK & CO., INC.

Health Technology

OREXO AB

Health Technology

ADDEX THERAPEUTICS LTD

Health Technology

KAROLINSKA DEVELOPMENT AB

Finance

Private companies12

Health Technology

Commercial Services

Commercial Services

Merck Sharp & Dohme Research Laboratories

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Producer Manufacturing

Commercial Services

Commercial Services

See company connections